Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways

BACKGROUND: Bicyclol, a novel synthetic antihepatitis drug, is widely known to protect against liver injury. However, few reports have focused on the possible effect of bicyclol on anti-proliferation and autophagy induction in cancer cells, particularly hepatocellular carcinoma cells. METHODS: In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Nie, Hao, Zhao, Xin, Qin, Yong, Gong, Xingguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031284/
https://www.ncbi.nlm.nih.gov/pubmed/27654866
http://dx.doi.org/10.1186/s12885-016-2767-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031284/
https://www.ncbi.nlm.nih.gov/pubmed/27654866
http://dx.doi.org/10.1186/s12885-016-2767-2

Ejemplares similares